The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria
Lian J. Pennings, Mike Marvin Ruth, Heiman Wertheim, Jakko van Ingen
Abstract
The parent drug SPR720 could have a role especially in MAC pulmonary disease treatment. Further studies in dynamic models and trials are ongoing to advance clinical development.
Topics & Concepts
Nontuberculous mycobacteriaBenzimidazoleMycobacterium avium complexMedicinePulmonary diseasePharmacologyMicrobiologyMycobacteriumTuberculosisIntensive care medicineInternal medicineBiologyChemistryPathologyOrganic chemistryMycobacterium research and diagnosisTuberculosis Research and EpidemiologyQuinazolinone synthesis and applications